Literature DB >> 14712367

Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.

E Perez-Trallero1, C Garcia, B Orden, J M Marimon, M Montes.   

Abstract

Reported here is an unusual cluster of non-invasive infections caused by an emm28 Streptococcus pyogenes strain resistant to bacitracin, erythromycin and clindamycin detected in Santander, Spain. Since one of the characteristics of group A streptococci is their almost uniform susceptibility to bacitracin, this finding was unusual, and a search for bacitracin-resistant Streptococcus pyogenes strains was conducted in two other distant cities of Spain (Madrid and San Sebastián) where their presence was confirmed. These strains were frequently associated with erythromycin- and clindamycin-resistance, and most of them belonged to a unique emm28 T28, ST52 clone.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14712367     DOI： 10.1007/s10096-003-1069-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

1.  Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone.

Authors:  M C Enright; B G Spratt; A Kalia; J H Cross; D E Bessen
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Detection of cross infection with Streptococcus pyogenes in a hospital.

Authors:  J H Ngui-Yen; M Walker
Journal:  Can J Infect Control       Date:  1992

3.  Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.

Authors:  J J Yan; H M Wu; A H Huang; H M Fu; C T Lee; J J Wu
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

4.  Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes.

Authors:  A Jasir; C Schalén
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

5.  Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

Authors:  E Perez-Trallero; M Urbieta; M Montes; I Ayestaran; J M Marimon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

6.  Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California.

Authors:  M K York; L Gibbs; F Perdreau-Remington; G F Brooks
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 9.  Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; J M Marimón; M Montes; B Orden; M de Pablos
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

10.  Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan.

Authors:  S Maruyama; H Yoshioka; K Fujita; M Takimoto; Y Satake
Journal:  Am J Dis Child       Date:  1979-11
View more
  8 in total

1.  Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.

Authors:  Liliana Mihaila-Amrouche; Anne Bouvet; Julien Loubinoux
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.

Authors:  Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José M García-Arenzana; Victor Iriarte
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.

Authors:  Emilio Pérez-Trallero; Milagrosa Montes; Beatriz Orden; Esther Tamayo; José M García-Arenzana; José M Marimón
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

Review 4.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

5.  Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.

Authors:  Edouard Bingen; Philippe Bidet; Liliana Mihaila-Amrouche; Catherine Doit; Samuel Forcet; Naïma Brahimi; Anne Bouvet; Robert Cohen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

6.  Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption.

Authors:  C Silva-Costa; A Friães; M Ramirez; J Melo-Cristino
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.

Authors:  Milagrosa Montes; Esther Tamayo; Beatriz Orden; Julián Larruskain; Emilio Perez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

8.  Antimicrobial susceptibility of Bacillus strains isolated from primary starters for African traditional bread production and characterization of the bacitracin operon and bacitracin biosynthesis.

Authors:  David B Adimpong; Kim I Sørensen; Line Thorsen; Birgitte Stuer-Lauridsen; Warda S Abdelgadir; Dennis S Nielsen; Patrick M F Derkx; Lene Jespersen
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.